These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3445996)

  • 21. Comparative investigations on the treatment of the varicose syndrome with 4-methyl-6,7-(bis-beta-diethyl-aminoethoxy)-coumarine hydrochloride (oxamarine), with the disodium salt of disulphuric ester of 4-methyl-aesculetol and with tri-hydroxy-ethylrutoside (troxerutin).
    Frandoli G; Turazza G; Spreafico PL
    Panminerva Med; 1972 Sep; 14(9):290-5. PubMed ID: 4618898
    [No Abstract]   [Full Text] [Related]  

  • 22. [Test of combination of the agents coumarin and troxerutin for embryotoxic and teratogenic side-effects in Göttingen miniature pigs (author's transl)].
    Grote W; Schulz LC; Drommer W; Uberschär S; Schäfer EA
    Arzneimittelforschung; 1977; 27(3):613-7. PubMed ID: 577429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.
    Roztocil K; Oliva I; Prerovský I; Linhart J
    Cor Vasa; 1989; 31(2):128-33. PubMed ID: 2663343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptomic analysis of gene expression in mice treated with troxerutin.
    Wang Y; Wei S; Chen L; Pei J; Wu H; Pei Y; Chen Y; Wang D
    PLoS One; 2017; 12(11):e0188261. PubMed ID: 29190643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A comparison of various phlebotonic agents on human endothelial cells of veins subjected to hypoxia].
    Remacle J; Houbion A; Michiels C
    Phlebologie; 1991; 44(4):881-9. PubMed ID: 1805259
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the haemolytic action of amphiphilic substances in vitro. Inhibition by O-(beta-hydroxyethyl)-rutosides.
    Biesendorfer H; Felix W; Wildenauer DB
    Biochem Pharmacol; 1981 Aug; 30(16):2287-92. PubMed ID: 7295341
    [No Abstract]   [Full Text] [Related]  

  • 27. [The behavior of blood clotting and its inhibitors under long term treatment with 5,6-benzo-alpha-pyrone (coumarin). Double blind study].
    Köstering H; Bandura B; Merten HA; Wieding JU
    Arzneimittelforschung; 1985; 35(8):1303-6. PubMed ID: 3907641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of mutagenic activity of troxerutin, a flavonoid derivative.
    Marzin D; Phi HV; Olivier P; Sauzieres J
    Toxicol Lett; 1987 Feb; 35(2-3):297-305. PubMed ID: 3824417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of a benzopyrone compound on liver function. Short communication (author's transl)].
    Cerlek S
    Arzneimittelforschung; 1977; 27(3):611-2. PubMed ID: 577428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticatatonic effect of venoruton.
    Aley KO; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):263-5. PubMed ID: 2898576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Kinetic effect characterization of 0-beta-hydroxyethylrutoside (Venoruton) in healthy probands].
    Ott B; Rehn D; Nocker W; Diebschlag W
    Vasa Suppl; 1991; 33():218. PubMed ID: 1788678
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of troxevasin on the aggregation capability of thrombocytes in children under 3 years of age with various forms of acute suppurative destructive pneumonia].
    Topuzov VS; Bevz SI; Chuĭko VA; Kolesnik OV; Diagelev II
    Klin Khir (1962); 1989; (6):26-7. PubMed ID: 2770138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of O-(beta-hydroxyethyl)-rutoside or venoruton on lactate dehydrogenase of human cultured varicose veins.
    Matagne D; Hamoir G
    Biochem Pharmacol; 1975 Aug; 24(16):1491-4. PubMed ID: 1191306
    [No Abstract]   [Full Text] [Related]  

  • 34. Venoruton in the therapy of central retinal vein occlusion.
    Zygulska-Mach H; Kostka-Trabka E; Kielar J; Grodzinska L; Dieron K; Kedzior A
    Ther Hung; 1985; 33(2):79-82. PubMed ID: 3842005
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influence of hydroxyethylrutoside on metabolism rate and biochemical functions of l-ascorbic acid in vitamin c--hyposaturated organisms of guinea pigs (author's transl)].
    Zloch Z
    Cas Lek Cesk; 1976 Jan; 115(2-3):87-92. PubMed ID: 1253208
    [No Abstract]   [Full Text] [Related]  

  • 36. [Follow-up treatment of vaginal hysterectomies using a bensopyrone preparation. Single-blind study on the subject of prevention of disorders of wound healing].
    Pethö A
    Fortschr Med; 1984 May; 102(17):493-6. PubMed ID: 6376299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Polymer-based delayed action matrices with solubility varying as a function of pH. II. Optimization of the formulation of cellulose matrices of trihydroxyethylrutin by direct compression].
    de Lemos G; Brossard C; Lefort des Ylouses D
    Pharm Acta Helv; 1982; 57(10-11):309-16. PubMed ID: 7146036
    [No Abstract]   [Full Text] [Related]  

  • 38. [Venalot used in therapy of phlebopathies].
    Lacativa AS
    Med Welt; 1980 May; 31(19):727-9. PubMed ID: 7421506
    [No Abstract]   [Full Text] [Related]  

  • 39. Troxerutin attenuates isoproterenol-induced cardiac hypertrophy via the LKB1/AMPK/mTOR pathway.
    Zhao J; Chen D; Feng C
    Panminerva Med; 2021 Jun; 63(2):233-234. PubMed ID: 31352760
    [No Abstract]   [Full Text] [Related]  

  • 40. Analgesic effect of O-(beta-hydroxy ethyl)rutoside in mice.
    Ramaswamy S; Pillai NP; Gopalakrishnan V; Parmar NS; Ghosh MN
    Indian J Exp Biol; 1985 Apr; 23(4):219-20. PubMed ID: 4077117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.